Abid Ur Rahman: Understanding the Coagulation Cascade and Hemostasis
Abid Ur Rahman, Laboratory Intern at Islamabad Diagnostic Centre, shared a post onĀ LinkedIn:
“Coagulation Cascade Simplified
The coagulation cascade is a complex series of enzymatic reactions that leads to the formation of a stable blood clot to prevent excessive bleeding after vascular injury.
It involves intrinsic, extrinsic, and common pathways, ultimately producing fibrin, which stabilizes the platelet plug.
Phases of Hemostasis
1.Vasoconstriction
- Immediate narrowing of blood vessels after injury
- Reduces blood loss
2.Primary Hemostasis
- Platelets adhere and aggregate at injury site
- Forms temporary platelet plug
3.Secondary Hemostasis (Coagulation Cascade)
- Activation of clotting factors
- Formation of fibrin clot
Extrinsic Pathway (Fast Pathway)
Initiated by tissue injury
Key Factor:
Factor VII (7) and Tissue Factor (Factor III)
Features:
- Rapid activation
- Evaluated by Prothrombin Time (PT/INR)
Pathway:
Tissue injury leads to Tissue Factor exposure, which activates Factor VII, resulting in Factor X activation.
Intrinsic Pathway (Slow Pathway)
Activated by damage within blood vessels
Key Factors:
Factor XII, Factor XI, Factor IX, and Factor VIII
Features:
- Slower but amplifies coagulation
- Evaluated by Activated Partial Thromboplastin Time (APTT)
Pathway:
Activation of Factor XII leads to activation of Factor XI, followed by activation of Factor IX together with Factor VIII, ultimately resulting in Factor X activation.
Common Pathway
Both intrinsic and extrinsic pathways merge here.
Key Factors:
Factor X, Factor V, Prothrombin, and Fibrinogen
Steps:
- Factor X converts Prothrombin into Thrombin
- Thrombin converts Fibrinogen into Fibrin
- Factor XIII stabilizes fibrin clot
Final Result:
Stable fibrin clot formation
Important Clotting Factors
Factor Name
- I Fibrinogen
- II Prothrombin
- III Tissue Factor
- IV Calcium
- VIII Anti-hemophilic factor A
- IX Christmas factor
- X Stuart-Prower factor
Natural Anticoagulants
- Antithrombin
- Protein C and Protein S
- Tissue Factor Pathway Inhibitor (TFPI)
Prevent excessive clot formation
Laboratory Tests Associated
- PT / INR evaluates Extrinsic pathway
- APTT evaluates Intrinsic pathway
- D-dimer reflects Fibrin degradation
- Fibrinogen assay assesses Clotting ability
Clinical Importance
Disorders of coagulation may lead to:
- Excessive bleeding (Hemophilia, DIC)
- Thrombosis (DVT, PE)
- Liver disease-related coagulopathy
- Vitamin K deficiency
Understanding the cascade is essential for interpreting coagulation tests and anticoagulant therapy.
The coagulation cascade transforms vascular injury into controlled clot formation, maintaining the balance between bleeding and thrombosis.”

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026